Chemotherapy and non-small-cell lung cancer.
Around 34,000 people in the UK die from lung cancer each year. Over 75% of patients with the disease have non-small-cell lung cancer (NSCLC). Here, we discuss the role of chemotherapy in the management of NSCLC, a treatment that some medical oncologists estimate would benefit 50% of patients with NSCLC, but which is given to fewer than 10%.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents